Furthermore, we could show that the majority of leukemia-initiating cells, defined as being CD34+/CD38−, expressed PVR and PVRL2 or at least one of the immune checkpoint ligands (mean expression value 77%, range 51–93%, n = 10). This evidence concerns the gene NECTIN2 and leukemia.